Received: from westeu12-emailsignatures-cloud.codetwo.com (13.93.42.39) by AMS0EPF000001AE.mail.protection.outlook.com (10.167.16.154) with Microsoft SMTP Server (version=TLS1_2, cipher=TLS_ECDHE_RSA_WITH_AES_256_GCM_SHA384) id 15.21.139.8 via Frontend Transport; Mon, 15 Jun 2026 11:51:01 +0000 Received: from AMS0EPF000001AE.eurprd05.prod.outlook.com (2603:10a6:401:5f::4) by CWLP123CA0099.outlook.office365.com (2603:10a6:401:5f::15) with Microsoft SMTP Server (version=TLS1_3, cipher=TLS_AES_256_GCM_SHA384) id 15.21.113.18 via Frontend Transport; Mon, 15 Jun 2026 11:51:02 +0000 Received: from DB3PR08CU002.outbound.protection.outlook.com (40.93.64.83) by westeu12-emailsignatures-cloud.codetwo.com with CodeTwo SMTP Server (TLS12) via SMTP; Mon, 15 Jun 2026 11:51:01 +0000 Received: from GV2PR02MB11921.eurprd02.prod.outlook.com ([fe80::9f24:8c81:10e8:7104]) by GV2PR02MB11921.eurprd02.prod.outlook.com ([fe80::9f24:8c81:10e8:7104%4]) with mapi id 15.21.0113.013; Mon, 15 Jun 2026 11:51:00 +0000 Received: from GV2PR02MB11921.eurprd02.prod.outlook.com (2603:10a6:150:351::5) by AS5PR02MB11296.eurprd02.prod.outlook.com (2603:10a6:20b:6c9::7) with Microsoft SMTP Server (version=TLS1_2, cipher=TLS_ECDHE_RSA_WITH_AES_256_GCM_SHA384) id 15.21.113.15; Mon, 15 Jun 2026 11:51:00 +0000 Received: from AS2PR02MB10123.eurprd02.prod.outlook.com (2603:10a6:20b:64f::12) by PA4PR02MB7085.eurprd02.prod.outlook.com with HTTPS; Mon, 15 Jun 2026 11:51:06 +0000 Received: from CWLP123CA0099.GBRP123.PROD.OUTLOOK.COM (2603:10a6:401:5f::15) by AS2PR02MB10123.eurprd02.prod.outlook.com (2603:10a6:20b:64f::12) with Microsoft SMTP Server (version=TLS1_2, cipher=TLS_ECDHE_RSA_WITH_AES_256_GCM_SHA384) id 15.21.113.18; Mon, 15 Jun 2026 11:51:02 +0000 From: "Kommunikatsioon - RA" To: =?iso-8859-1?Q?Keiu_P=F5derson_-_RA?= References: In-Reply-To: Subject: Ed: Palve EBUst Date: Mon, 15 Jun 2026 14:51:00 +0300 Message-ID: MIME-Version: 1.0 Content-Type: multipart/alternative; boundary="----=_NextPart_000_00FA_01DD07B8.9749DC80" X-Mailer: Microsoft Outlook 16.0 Thread-Index: AQHZqoIQxGgZNN4n7jGbd9YJGhM6HQI1XvG/AlzBKms= Authentication-Results: spf=pass (sender IP is 13.93.42.39) smtp.mailfrom=ravimiamet.ee; dkim=none (message not signed) header.d=none;dmarc=pass action=none header.from=ravimiamet.ee; X-MS-Has-Attach: X-MS-Exchange-Organization-SCL: 1 X-MS-TNEF-Correlator: x-codetwoprocessed: true X-MS-Exchange-Organization-MessageDirectionality: Originating X-MS-Exchange-Organization-AuthSource: GV2PR02MB11921.eurprd02.prod.outlook.com X-MS-Exchange-Organization-AuthAs: Internal X-MS-Exchange-Organization-AuthMechanism: 04 X-MS-Exchange-Organization-Network-Message-Id: 80a95091-37ad-4108-ae42-08decad45f9c X-MS-PublicTrafficType: Email X-MS-TrafficTypeDiagnostic: GV2PR02MB11921:EE_|AS5PR02MB11296:EE_|AMS0EPF000001AE:EE_|AS2PR02MB10123:EE_|PA4PR02MB7085:EE_ X-MS-Exchange-Organization-ExpirationStartTime: 15 Jun 2026 11:51:01.9170 (UTC) X-MS-Exchange-Organization-ExpirationStartTimeReason: OriginalSubmit X-MS-Exchange-Organization-ExpirationInterval: 1:00:00:00.0000000 X-MS-Exchange-Organization-ExpirationIntervalReason: OriginalSubmit X-MS-Office365-Filtering-Correlation-Id: 80a95091-37ad-4108-ae42-08decad45f9c X-MS-Exchange-AtpMessageProperties: SA X-Microsoft-Antispam: BCL:0;ARA:13230040|39142699007|31052699007|366016|35042699022|82310400026|23010399003|55112099003|8096899003|56012099006|11063799006|4143699003|22082099003|13003099007|18002099003|41050700001; X-Forefront-Antispam-Report: CIP:13.93.42.39;CTRY:NL;LANG:et;SCL:1;SRV:;IPV:NLI;SFV:NSPM;H:westeu12-emailsignatures-cloud.codetwo.com;PTR:westeu12-emailsignatures-cloud.codetwo.com;CAT:NONE;SFS:(13230040)(39142699007)(31052699007)(366016)(35042699022)(82310400026)(23010399003)(55112099003)(8096899003)(56012099006)(11063799006)(4143699003)(22082099003)(13003099007)(18002099003)(41050700001);DIR:INT; X-MS-Exchange-CrossTenant-OriginalArrivalTime: 15 Jun 2026 11:51:01.8962 (UTC) X-MS-Exchange-CrossTenant-FromEntityHeader: HybridOnPrem X-MS-Exchange-CrossTenant-Id: 8fe098d2-428d-4bd4-9803-7195fe96f0e2 X-MS-Exchange-CrossTenant-AuthSource: GV2PR02MB11921.eurprd02.prod.outlook.com X-MS-Exchange-CrossTenant-AuthAs: Internal X-MS-Exchange-CrossTenant-Network-Message-Id: 80a95091-37ad-4108-ae42-08decad45f9c X-MS-Exchange-Transport-CrossTenantHeadersStamped: AS5PR02MB11296 X-MS-Exchange-Transport-CrossTenantHeadersStamped: AS2PR02MB10123 X-MS-Exchange-Transport-EndToEndLatency: 00:00:04.6716271 X-MS-Exchange-Processed-By-BccFoldering: 15.21.0113.000 X-MS-Exchange-ExternalInOutlookResult: NotEnabled X-Microsoft-Antispam-Mailbox-Delivery: ucf:0;jmr:0;auth:0;dest:I;ENG:(910005)(944506478)(944626604)(920097)(425001)(930201)(20251009189)(140003); X-Microsoft-Antispam-Message-Info: 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 Content-Language: et x-ms-exchange-organization-originalserveripaddress: 10.167.16.154 x-ms-exchange-organization-originalclientipaddress: 45.156.32.33 acceptlanguage: et-EE, en-US msip_labels: MSIP_Label_defa4170-0d19-0005-0004-bc88714345d2_Enabled=True;MSIP_Label_defa4170-0d19-0005-0004-bc88714345d2_SiteId=8fe098d2-428d-4bd4-9803-7195fe96f0e2;MSIP_Label_defa4170-0d19-0005-0004-bc88714345d2_SetDate=2026-06-15T11:50:59.668Z;MSIP_Label_defa4170-0d19-0005-0004-bc88714345d2_Name=All Employees (unrestricted);MSIP_Label_defa4170-0d19-0005-0004-bc88714345d2_ContentBits=1;MSIP_Label_defa4170-0d19-0005-0004-bc88714345d2_Method=Standard; X-OlkEid: 00000000FBE30D4A7ED77B47974B2304BB4E84D8070034AD76187591974DBF6C4F76951C873A0100020000000000B3D5AF184A00AB4C8C167C2EB8411B9B0000000015400000C31F351B97D8CC4287338315397D1727 X-EOPAttributedMessage: 0 received-spf: Pass (protection.outlook.com: domain of ravimiamet.ee designates 13.93.42.39 as permitted sender) receiver=protection.outlook.com; client-ip=13.93.42.39; helo=westeu12-emailsignatures-cloud.codetwo.com; pr=C authentication-results-original: dkim=none (message not signed) header.d=none;dmarc=none action=none header.from=ravimiamet.ee; X-Microsoft-Antispam-Untrusted: BCL:0;ARA:13230040|366016|23010399003|31052699007|39142699007|55112099003|4143699003|11063799006|56012099006|8096899003|13003099007|18002099003|22082099003|41050700001; X-Microsoft-Antispam-Message-Info-Original: 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 X-Forefront-Antispam-Report-Untrusted: CIP:255.255.255.255;CTRY:;LANG:et;SCL:1;SRV:;IPV:NLI;SFV:NSPM;H:GV2PR02MB11921.eurprd02.prod.outlook.com;PTR:;CAT:NONE;SFS:(13230040)(366016)(23010399003)(31052699007)(39142699007)(55112099003)(4143699003)(11063799006)(56012099006)(8096899003)(13003099007)(18002099003)(22082099003)(41050700001);DIR:INT; X-Exchange-RoutingPolicyChecked: VtAy4nNW4sHKs1J9Zbh9DooCxUAbW51iM3Awjgq5tTX6Xau7xwEd2CgMEr+t9tl9KksnhI8Mvg9o/nyYwCdc5F02E9c+PaQWny0fc3AzKQXIpNFFo/bE/3LYOV3l+QYNHmOg90KMmAMJ2NgADrCQKtfJiGnQXYjKsZKt8KIaYDKHXRkiWfLKgn1d/VDss7UuyTrlET5LCDwGCmhxAJoKChfFg0EVCeVLuFk767Xqy3BuuymPGNMwUVmLe/PtXPUFNINIzO73CoZPqwqEu8WN6NZDGelimAbMjxydwLjg4+g9+fGe8/mlMXbloE/Tp7V0T2dyajVXdrh7Kki1hCWCjQ== X-OrganizationHeadersPreserved: AS5PR02MB11296.eurprd02.prod.outlook.com X-CodeTwo-MessageID: 54f8c860-18f4-4e81-97c4-1bbc0ac88301.20260615115101@westeu12-emailsignatures-cloud.codetwo.com X-CrossPremisesHeadersPromoted: AMS0EPF000001AE.eurprd05.prod.outlook.com X-CrossPremisesHeadersFiltered: AMS0EPF000001AE.eurprd05.prod.outlook.com X-MS-Exchange-Transport-CrossTenantHeadersStripped: AMS0EPF000001AE.eurprd05.prod.outlook.com X-OriginatorOrg: m1wmgpm3xrpm87txzdfw82by7.smtp.codetwo.online X-MS-Office365-Filtering-Correlation-Id-Prvs: edac7deb-67a3-48b3-71a4-08decad45e99 X-MS-Exchange-CrossTenant-OriginalAttributedTenantConnectingIp: TenantId=8fe098d2-428d-4bd4-9803-7195fe96f0e2;Ip=[13.93.42.39];Helo=[westeu12-emailsignatures-cloud.codetwo.com] This is a multipart message in MIME format. ------=_NextPart_000_00FA_01DD07B8.9749DC80 Content-Type: text/plain; charset="iso-8859-1" Content-Transfer-Encoding: 8bit _____ Saatja: Kristi Sarap - RA Saadetud: esmaspäev, 15. juuni 2026 14:50 Adressaat: Hanneli Rudi Teema: Vs: Palve EBUst Tere, Hanneli! Meie bioloogiliste preparaatide osakonna spetsialist Siim Suutre vastab sulle nii: "Vastavalt Euroopa Liidu direktiivide biovalvsuse nõuetele on Taani käitleja kohustatud blokeeringust teavitama ka kliinikuid, kuhu asjassepuutuva doonori materjali on saadetud. Kliinik omakorda saab juba peresid teavitada ja vastavad abinõud kasutusele võtta. RATC teated on mõeldud riikide järelevalveasutustele, et anda võimalus topeltkontrolliks. Eestis on Ravimiamet pärast RATC teate saamist kliinikutelt ka vajalike biovalvsustoimingute kohta küsinud. Konkreetsel juhul saame öelda, et doonori NIMA kohta Ravimiametini infot jõudnud ei ole. Palume võimalusel täpsustada, kas RATC teade selle kohta peaks olema saadetud 2026. aastal?" Kristi Sarap kommunikatsiooninõunik Ravimiamet Ravimiamet 737 4140 www.ravimiamet.ee Selles e-kirjas sisalduv teave (kaasa arvatud manused) on mõeldud ametialaseks kasutamiseks ning seda võivad kasutada vaid e-kirja adressaadid. E-kirjas sisalduvat teavet ei tohi ilma saatja selgelt väljendatud loata edasi saata ega mis tahes viisil kolmandatele isikutele avaldada. Juhul, kui Te olete saanud käesoleva e-kirja eksituse tõttu, teavitage sellest koheselt saatjat ning kustutage e-kiri. This e-mail and any attachments transmitted may contain confidential and privileged information. If you are not the intended recipient, please notify the sender immediately by returning the e-mail and permanently deleting what you have received. Any dissemination or use of this information by a third person without permission is prohibited and may be illegal. _____ Saatja: Hanneli Rudi Saadetud: esmaspäev, 15. juuni 2026 11:03 Adressaat: Kommunikatsioon - RA Teema: Palve EBUst Tähelepanu! Tegemist on välisvõrgust saabunud kirjaga. Tundmatu saatja korral palume linke ja faile mitte avada. Tere Pöördun teie poole taas oma EBU kolleegi palvel. Taani ametivõimude teatel on blokeeritud doonori NIMA spermat kasutatud Next Fertility Nordic kliinikus, mis tegutseb Tallinnas. Mu kolleeg soovib teada, kui RATC süsteemi kaudu edastatakse kiirhoiatus, mille tulemusena konkreetse doonori sperma kasutamine blokeeritakse, aga puudub vastav register ja ametivõimude järelevalve, siis kuidas tagatakse asjasse puutuvate perede teavitamine? Kas kliinik sai teada, aga ka kuidas kliinik peaks teada saama, et selle doonori spermat mitte kasutada? Loodan, et saan Teie vastuse lähipäevil. Hanneli Rudi AK toimetaja 55 35 816 ------=_NextPart_000_00FA_01DD07B8.9749DC80 Content-Type: text/html; charset="iso-8859-1" Content-Transfer-Encoding: quoted-printable

Saatja: Kristi Sarap - = RA <kristi.sarap@ravimiamet.ee>
Saadetud: esmasp=E4ev, 15. juuni 2026 14:50
Adressaat: Hanneli Rudi <hanneli.rudi@err.ee>
Teema: Vs: Palve EBUst
 
Tere, Hanneli!

Meie bioloogiliste preparaatide osakonna spetsialist Siim Suutre vastab = sulle nii: 

"Vastavalt Euroopa Liidu direktiivide biovalvsuse n=F5uetele on = Taani k=E4itleja kohustatud blokeeringust teavitama ka kliinikuid, kuhu = asjassepuutuva doonori materjali on saadetud. Kliinik omakorda saab juba = peresid teavitada ja vastavad abin=F5ud kasutusele v=F5tta. RATC teated on m=F5eldud riikide j=E4relevalveasutustele, et anda = v=F5imalus topeltkontrolliks. Eestis on Ravimiamet p=E4rast RATC teate = saamist kliinikutelt ka vajalike biovalvsustoimingute kohta k=FCsinud. = Konkreetsel juhul saame =F6elda, et doonori NIMA kohta Ravimiametini infot j=F5udnud ei ole. Palume v=F5imalusel t=E4psustada, kas RATC = teade selle kohta peaks olema saadetud 2026. aastal?"


Kristi Sarap

kommunikatsioonin=F5unik

Ravimiamet


Ravimiamet

737 4140

www.ravimiamet.ee


Selles e-kirjas sisalduv teave (kaasa arvatud = manused) on m=F5eldud ametialaseks kasutamiseks ning seda v=F5ivad = kasutada vaid e-kirja adressaadid. E-kirjas sisalduvat teavet ei tohi ilma saatja selgelt = v=E4ljendatud loata edasi saata ega mis tahes viisil kolmandatele = isikutele avaldada. Juhul, kui Te olete saanud k=E4esoleva e-kirja = eksituse t=F5ttu, teavitage sellest koheselt saatjat ning kustutage e-kiri. 
This e-mail and any attachments transmitted may = contain confidential and privileged information. If you are not the = intended recipient, please notify the sender immediately by = returning the e-mail and permanently deleting what you have = received. Any dissemination or use of this information by a third person without permission is = prohibited and may be illegal. 

Saatja: = Hanneli Rudi <hanneli.rudi@err.ee>
Saadetud: esmasp=E4ev, 15. juuni 2026 11:03
Adressaat: Kommunikatsioon - RA <press@ravimiamet.ee>
Teema: Palve EBUst
 

T=E4helepanu! Tegemist on v=E4lisv=F5rgust saabunud kirjaga.
Tundmatu saatja korral palume linke ja faile mitte avada.
Tere

P=F6=F6rdun teie poole taas oma EBU kolleegi palvel. Taani = ametiv=F5imude teatel on blokeeritud doonori NIMA spermat kasutatud Next = Fertility Nordic kliinikus, mis tegutseb Tallinnas.
Mu kolleeg soovib teada, kui RATC s=FCsteemi kaudu edastatakse = kiirhoiatus, mille tulemusena konkreetse doonori sperma kasutamine = blokeeritakse, aga puudub vastav register ja ametiv=F5imude = j=E4relevalve, siis kuidas tagatakse asjasse puutuvate perede = teavitamine? Kas kliinik sai teada, aga ka kuidas kliinik peaks teada saama, et = selle doonori spermat mitte kasutada?

Loodan, et saan Teie vastuse l=E4hip=E4evil.

Hanneli Rudi
AK toimetaja
55 35 816



------=_NextPart_000_00FA_01DD07B8.9749DC80--